News

Find News

Filter articles

Showing 41 to 50 of 2541 results

Eli Lilly releases generic insulin injection

US23-05-2019

Eli Lilly has released a generic insulin injection at half of the list price of its identical branded medicine to the US market.

City of Baltimore accuses Janssen of delaying generics

US23-05-2019

Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is being sued for “unlawfully” delaying generic competition to Zytiga, its branded cancer medication.

Merck boosts oncology pipeline with $1bn deal

US22-05-2019

Merck has announced plans to acquire Peloton Therapeutics, a clinical-stage biopharmaceutical company, in a $1.05 billion bid to boost its oncology pipeline.

Alphabet's Verily in digital research alliance with Pfizer and others

22-05-2019

Verily, which is a subsidiary of Google’s parent company Alphabet, yesterday announced that it had partnered with Novartis, Otsuka, Pfizer, and Sanofi in efforts to develop digitally-innovative clinical research programmes.

Genentech enters agreement to develop autoimmune therapies

US21-05-2019

US-based biopharmaceutical company Parvus Therapeutics has entered into a collaboration and licensing agreement with Genentech, a subsidiary of Roche.

Gilead claims US government PrEP patents are invalid

US20-05-2019

Gilead’s CEO has told a US House of Representatives committee that three Centers for Disease Control HIV prevention patents are invalid.

Delhi High Court issues landmark nutraceuticals judgment

India20-05-2019

The High Court of Delhi has ruled that the test for passing off of so-called nutraceuticals should be the same as that for pharmaceuticals.

Federal Circuit invalidates Nuvo’s Vimovo patents

US17-05-2019

The US Court of Appeals for the Federal Circuit has delivered a blow to Nuvo Pharmaceuticals by reversing a decision which had upheld the validity of the Canadian company’s pain relief drug Vimovo.

EU adopts SPC manufacturing waiver

EU16-05-2019

The European Union has adopted the proposed supplementary protection certificate manufacturing waiver, despite criticism from parts of the pharmaceutical industry.

Federal Circuit rules against J&J in Zytiga dispute

US16-05-2019

The US Court of Appeals for the Federal Circuit delivered a blow to Johnson & Johnson on Tuesday, May 14, by confirming the invalidation of a patent covering blockbuster prostate cancer drug Zytiga.

Showing 41 to 50 of 2541 results

LSIPR